[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_4988 

# __Reliance on carbon-based materials and composites for antiviral properties__

## Articles mentionning the risk

* [Ayub_graphene-based_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_404.md)

## Mitigations of this risk

* [Research and development of alternative antiviral coatings, validation of antiviral properties](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_6861.md)

## Name of the risk

Ineffectiveness in disrupting virus transmission, leading to continued risk of infectious viruses

## People affected by this risk

* [General public](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_68.md)
* [Healthcare workers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_29.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)

## Stakeholders who can mitigate this risk

* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Technology developers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_761.md)

## Technologies linked to the risk

* [Graphene oxide go](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6051.md)
* [Graphene-based nanocomposites gbns](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6052.md)
* [Reduced graphene oxide rgo](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6053.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

## This Risk belongs to this RiskSubgroup

* [Healthcare and medical risks](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_15.md)

